NYSE$USPH
US Physical Therapy Inc · Q2 2023 earnings
Q2 2023 earnings · · Investor relations
Briefing
U.S. Physical Therapy's Q2 2023 earnings were reported, featuring record-high quarterly patient volume and a 9.4% increase in net patient revenue from physical therapy operations.
U.S. Physical Therapy reported a 7.7% increase in total net revenue to $151.5 million, driven by record patient volumes and new clinic additions, although net income decreased due to higher interest expenses. Management reaffirmed its Adjusted EBITDA guidance for 2023.
- Adjusted EBITDA increased to $21.7 million, up from $21.3 million in the second quarter of 2022.
- Net patient revenue from physical therapy operations rose by 9.4% to $129.3 million.
- Average visits per clinic per day reached an all-time high of 30.4.
- The company added 13 clinics and closed four, bringing the total to 656 clinics as of June 30, 2023.
Headline financials
Revenue & EPS history
US Physical Therapy · Revenue · Quarterly
$151M
Revenue by segment
US Physical Therapy · $130M total across 1 segment · Q2 2023
- Physical Therapy Operations$130M+9.2%100.0%
Forward guidance
Management reaffirms that it currently expects the Company’s Adjusted EBITDA for 2023 to be in the range of $75.0 million to $80.0 million.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2023
-0.6%
Avg return
Earnings day
-0.5%
Avg return
5 days after
-1.3%
Avg return
30 days after
53%
35 / 66 earnings
Positive
+17.3%
Q3 2024
Best reaction
-27.5%
Q2 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.5% | +1.3% | +7.5% | |
| Q4 2025 | -2.9% | +1.9% | -8.5% | |
| Q3 2025 | +0.9% | -15.8% | -13.8% | |
| Q2 2025 | +14.7% | +20.4% | +17.8% | |
| Q1 2025 | -0.1% | +8.8% | +8.9% | |
| Q4 2024 | -6.0% | -9.5% | -18.0% | |
| Q3 2024 | +17.3% | +14.8% | +17.9% | |
| Q2 2024 | -6.8% | -3.9% | -5.4% | |
| Q1 2024 | -2.2% | +0.2% | -8.0% | |
| Q4 2023 | +3.4% | +2.8% | +9.8% | |
| Q3 2023 | -2.8% | -3.3% | +4.3% | |
| Q2 2023 | -8.6% | -8.1% | -19.8% | |
| Q1 2023 | +4.5% | +10.1% | +2.1% | |
| Q4 2022 | +2.1% | +2.2% | -5.7% | |
| Q3 2022 | -8.9% | -4.0% | -0.3% | |
| Q2 2022 | -27.5% | -29.9% | -37.0% | |
| Q1 2022 | -4.4% | -4.1% | +4.2% | |
| Q4 2021 | -5.8% | -6.5% | -2.1% | |
| Q3 2021 | -3.6% | -8.2% | -21.6% | |
| Q2 2021 | -3.6% | -5.4% | -1.1% | |
| Q1 2021 | +6.0% | +4.5% | +6.6% | |
| Q4 2020 | -17.2% | -19.8% | -24.3% | |
| Q3 2020 | +8.4% | +26.6% | +29.2% | |
| Q2 2020 | +2.4% | +1.1% | +3.7% | |
| Q1 2020 | -1.0% | +2.7% | +0.9% | |
| Q4 2019 | -17.7% | -16.0% | -49.0% | |
| Q3 2019 | -20.1% | -20.4% | -20.5% | |
| Q2 2019 | +3.9% | +6.1% | +8.1% | |
| Q1 2019 | +2.3% | +3.3% | -1.2% | |
| Q4 2018 | +3.2% | +3.4% | +2.1% | |
| Q3 2018 | +5.1% | +6.5% | +10.7% | |
| Q2 2018 | +8.9% | +7.0% | +18.9% | |
| Q1 2018 | -1.4% | -0.5% | +2.4% | |
| Q4 2017 | +6.8% | +2.7% | +4.9% | |
| Q3 2017 | -2.6% | -2.9% | +5.7% | |
| Q2 2017 | +2.4% | +2.6% | -2.9% | |
| Q1 2017 | -6.0% | +0.8% | -2.1% | |
| Q4 2016 | +1.7% | +2.0% | -1.2% | |
| Q3 2016 | -1.2% | +0.5% | +14.3% | |
| Q2 2016 | +4.7% | +4.0% | +9.7% | |
| Q1 2016 | +12.7% | — | — | |
| Q4 2015 | +1.2% | — | — | |
| Q3 2015 | +2.3% | — | — | |
| Q2 2015 | -5.0% | — | — | |
| Q1 2015 | +7.9% | — | — | |
| Q4 2014 | +5.4% | — | — | |
| Q3 2014 | -7.2% | — | — | |
| Q2 2014 | +5.8% | — | — | |
| Q1 2014 | +3.0% | — | — | |
| Q4 2013 | -0.3% | — | — | |
| Q3 2013 | -7.1% | — | — | |
| Q2 2013 | +6.0% | — | — | |
| Q1 2013 | +3.5% | — | — | |
| Q4 2012 | -4.6% | — | — | |
| Q3 2012 | +0.6% | — | — | |
| Q2 2012 | +0.6% | — | — | |
| Q1 2011 | +1.0% | — | — | |
| Q1 2012 | +2.1% | — | — | |
| Q4 2009 | -0.2% | — | — | |
| Q4 2011 | -0.2% | — | — | |
| Q3 2011 | +1.9% | — | — | |
| Q3 2010 | +1.9% | — | — | |
| Q2 2010 | -10.9% | — | — | |
| Q2 2011 | -10.9% | — | — | |
| Q4 2010 | -10.9% | — | — | |
| Q1 2010 | +12.8% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro